FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to dermatology and leprology, and deals with correction of anemia, induced by introduction of preparation dapsone in experiment. For this purpose used is alpha-tocopherol acetate, which is introduced in combination with dapsone to white non-linear male rats per os in dose 2-10 mg/kg 1 time per day for 21 days.
EFFECT: mode of alpha-tocopherol acetate ensures efficient correction of dapsone-induced hemolytic anemia, with absent side effects.
5 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EXPERIMENTAL CORRECTION OF NEUROTOXIC ACTION OF DAPSONE | 2013 |
|
RU2525180C1 |
| METHOD FOR TREATING NEPHROANGIOPATHY COMBINED WITH ALLOXAN DIABETES IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2372898C1 |
| ANTIOXIDANT PREPARATION FOR ANIMALS | 2010 |
|
RU2435572C1 |
| METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
| METHOD FOR OXIDATIVE STRESS CORRECTION UNDER CONDITIONS OF ULTRAVIOLET IRRADIATION | 2016 |
|
RU2619875C1 |
| METHOD FOR PREVENTING CHRONIC LEAD COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2019 |
|
RU2706386C1 |
| METHOD OF PREVENTING TOXIC EFFECT OF CADMIUM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410763C1 |
| ANTILEPROTIC OF BACTERIOSTATIC AND BACTERICIDE ACTIVITY RELATING TO M. LUFU, REPRESENTING O-BENZOYLAMINOBENZOIC ACID | 2016 |
|
RU2638926C2 |
| METHOD OF TREATMENT OF ANEMIC SYNDROME IN CHILDREN ASSOCIATED WITH PERIORAL IMPACT OF MANGANESE AND CHLOROFORM FROM DRINKING WATER | 2017 |
|
RU2662148C1 |
| METHOD FOR PREVENTION OF CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2018 |
|
RU2683723C1 |
